Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999–2015). TREND-AR study

Abstract

PurposeTo analyse trends in hip fracture (HF) rates in patients with rheumatoid arthritis (RA) over an extended time period (17 years).MethodsThis observational retrospective survey was performed by reviewing data from the National Surveillance System for Hospital Data, which includes more than 98% of Spanish hospitals. All hospitalisations of patients with RA and HF that were reported from 1999 to 2015 were analysed. Codes were selected using the Ninth International Classification of Diseases, Clinical Modification: ICD-9-CM: RA 714.0 to 714.9 and HF 820.0 to 820.3. The crude and age-adjusted incidence rate of HF was calculated by age and sex strata over the last 17 years. General lineal models were used to analyse trends.ResultsBetween 1999 and 2015, 6656 HFs occurred in patients with RA of all ages (84.25% women, mean age 77.5 and 15.75% men, mean age 76.37). The age-adjusted osteoporotic HF rate was 221.85/100 000 RA persons/ year (women 227.97; men 179.06). The HF incidence rate increased yearly by 3.1% (95% CI 2.1 to 4.0) during the 1999–2015 period (p<0.001) and was more pronounced in men (3.5% (95% CI 2.1 to 4.9)) than in women (3.1% (95% CI 2.3 to 4.1)). The female to male ratio decreased from 1.54 in 1999 to 1.14 in 2015. The average length of hospital stays (ALHS) decreased (p<0.001) from 16.76 days (SD 15.3) in 1999 to 10.78 days (SD 7.72) in 2015. Age at the time of hospitalisation increased (p<0.001) from 75.3 years (SD 9.33) in 1999 to 79.92 years (SD 9.47) in 2015. There was a total of 326 (4.9%) deaths during admission, 247 (4.4%) in women and 79 (7.5%) in men (p<0.001).ConclusionIn Spain, despite the advances that have taken place in controlling disease activity and in treating osteoporosis, the incidence rate of HF increased in both male and female patients with RA.

Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide

“…Despite the effective treatment options available nowadays compared with 2–3 decades ago, RA patients still suffer from an increased risk for fractures [108]. One of the most threatening reasons for the high incidence of fractures, next to aging, and the low adherence of osteoporotic drugs, is the ongoing use of corticosteroids, resulting in GIOP.…”

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target

“…Indeed, treatment with bisphosphonates was the strongest predictor of maintenance of the BMD at any site. The reasons for the selective slight decline in the BMD at the FN irrespective of disease and treatment-related variables remain poorly understood, but recent studies have suggested that hip fragility may be an intrinsic characteristic of RA ( 38 , 39 ).…”

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients

“…Osteoporosis was frequently noted in this population; of note, the nurses who collected information relating to fractures noted all fractures, whatever the cause, which may have overestimated events. However, fractures are frequent in RA and furthermore, this can be explained in part by glucocorticoid intake in RA patients 16 17…”

“…Infections are frequent in RA due to iatrogenic immunodepresssion 3. Finally, osteoporosis is a frequent comorbidity, and RA is considered a risk factor for osteoporosis in the FRAX risk tool endorsed by the WHO 16–18…”